News

NewEdge Wealth CEO Rob Sechan owns it and breaks it down, while the Investment Committee drops their latest picks.
Microsoft and Meta's strong earnings reports eased investor fears of an economic slowdown amid President Trump's tariffs.
On this week’s episode of the Readout LOUD, we review President Trump’s first 100 days, the return of biotech M&A, strong ...
Day for drug tariffs ticks closer, the pharmaceutical industry doesn’t know what to think.The Trump administration said in ...
Wegovy and Zepbound are part of a wave of obesity medications known as GLP-1 receptor agonists that have soared in popularity ...
President Donald Trump has set his sights on the pharmaceutical industry to shoulder part of the cost of his tax cuts, pressing congressional Republicans to force drugmakers to accept lower prices on ...
President Donald Trump’s trade representative said that the US was nearing an announcement of a first tranche of trade deals ...
After 115 days of heartbreak and hope, Dipayan and Kasturi finally reunited with their beloved dog, Greyhound. Lost in Agra, ...
While speaking with business leaders at an economic event at the White House, President Trump said that since his return to ...
U.S. stocks rallied on Thursday, with the Dow and S&P 500 posting their eighth straight session of gains after strong results ...
More than 300 students played a rendition of "What A Wonderful World" right before Lilly learned she was going to Disney ...
At Stanford’s Drug Discovery Symposium, biotech executives spoke openly about how the scientific ecosystem is now in jeopardy ...